MX9707295A - Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10. - Google Patents

Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10.

Info

Publication number
MX9707295A
MX9707295A MX9707295A MX9707295A MX9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A
Authority
MX
Mexico
Prior art keywords
enhancing
interleukin
antibody response
specific antigens
vaccine
Prior art date
Application number
MX9707295A
Other languages
English (en)
Other versions
MXPA97007295A (es
Inventor
Michael J Grace
Jay S Fine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9707295A publication Critical patent/MX9707295A/es
Publication of MXPA97007295A publication Critical patent/MXPA97007295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a un método para mejorar la respuesta inmune de un mamífero a una vacuna, el método comprende la administracion, a este mamífero, de un cantidad efectiva de IL-10 junto con la vacuna. Una composicion farmacéutica que contiene una cantidad efectiva de IL-10, un antígeno natural, sintético o recombinante y un portador farmacéuticamente aceptable.
MXPA/A/1997/007295A 1995-03-24 1997-09-24 Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10 MXPA97007295A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08410199 1995-03-24
US08/410,199 US5866134A (en) 1995-03-24 1995-03-24 Method for enhancing the antibody response to specific antigens with Interleukin-10
PCT/US1996/003311 WO1996030039A1 (en) 1995-03-24 1996-03-21 Method for enhancing the antibody response to specific antigens with interleukin-10

Publications (2)

Publication Number Publication Date
MX9707295A true MX9707295A (es) 1997-11-29
MXPA97007295A MXPA97007295A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CA2215968A1 (en) 1996-10-03
AU711087B2 (en) 1999-10-07
HUP9801223A3 (en) 2000-12-28
US5866134A (en) 1999-02-02
AU5189096A (en) 1996-10-16
NZ304640A (en) 1999-07-29
WO1996030039A1 (en) 1996-10-03
KR19980703251A (ko) 1998-10-15
HUP9801223A2 (hu) 1998-08-28
EP0814829A1 (en) 1998-01-07
JPH11502533A (ja) 1999-03-02

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
EP0618813A4 (en) Antigen of hybrid m protein and carrier for group a streptococcal vaccine.
IL102687A (en) Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
AU7980794A (en) Methods and compositions for microencapsulation of antigens for use as vaccines
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
IE900502L (en) Conjugates
ES8608883A1 (es) Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular.
MY135673A (en) Monoclonal antibodies for inducing tolerance
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
AU1749292A (en) Recombinant hybrid porin epitopes
EP0153871A3 (en) Antibody enhancement of immunogenicity of antigen
AU4803785A (en) Cross-reactive and protective epitopes of circumsporozoite proteins
HU9301797D0 (en) Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction
CA2128247A1 (en) Vaccines based on streptokinase
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
ATE175357T1 (de) Empfängnisverhütender impfstoff
NZ223624A (en) Peptide immunogen from streptococcus mutans, vaccines and antibodies
AU5217890A (en) Monoclonal antibodies in vaccine formulations
GB2238959B (en) Antigen and conjugates thereof for suppressing immune response
AU3752489A (en) Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto